Parsonage-turner syndrome associated with SARS-CoV2 (COVID-19) infection

Mitry, Maria; Collins, Lee K.; Kazam, J. Jacob; Kaicker, Shipra; Kovanlıkaya, Arzu

doi:10.1016/j.clinimag.2020.11.017

Cited by 52 publications

(81 citation statements)

References 9 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reported case presents similar clinical characteristics to the first reported case of a possible association between COVID-19 and PTS 8 . However, we believe that an electrodiagnostic study will be key to being able to increase the diagnostic precision in relation to this pathology 8 .…”

Section: Discussionsupporting

confidence: 74%

See 1 more Smart Citation

Parsonage-Turner syndrome association with SARS-CoV-2 infection

Díaz

Contreras

Muñoz

et al. 2021

JSES Reviews, Reports, and Techniques

View full text Add to dashboard Cite

Parsonage-Turner syndrome (PTS), also known as idiopathic brachial plexopathy or neuralgic amyotrophy, was first described by Julius Dreschfeld in 1887. PTS is characterized by a single or multiple mononeuropathies at the level of the brachial plexus (not exclusive), acute and self-limited, associated with motor deficit and muscle atrophy. The exact pathophysiology is still unknown. Of the many proposed causes, an infectious or immune-mediated process seems to be the most supported. Viral illness is the most common associated risk factor (25% to 55%). Currently, there are only three case reports in the literature on the relation of COVID-19 with PTS. The COVID- 19 neurological involvement has been described mainly at the central nervous system, with Guillain-Barré syndrome being the most frequent at the peripheral nervous system. In the context of a coronavirus pandemic, we should suspect this disease in patients with neuropathic pain in the shoulder region within the possible differential diagnoses. This publication is about a case of PTS in association with COVID-19 and a review of scientific literature available.

show abstract

Section: Discussionsupporting

confidence: 74%

“…Currently, there are only three case reports in the literature on the relation of COVID-19 with PTS 1 , 8 , 14 . The COVID-19 neurological involvement has been described mainly at the central nervous system, with Guillain-Barré syndrome being the most frequent at the peripheral nervous system 2 .…”

mentioning

confidence: 99%

Parsonage-Turner syndrome association with SARS-CoV-2 infection

Díaz

Contreras

Muñoz

et al. 2021

JSES Reviews, Reports, and Techniques

View full text Add to dashboard Cite

show abstract

“…Aside from GBS and its variants, post-infectious immune-mediated neuropathies secondary to COVID-19 have been rarely reported to date [ 5 , 17 ]. A single case report of an otherwise healthy 17-year-old patient describes Parsonage-Turner syndrome (neuralgic amyotrophy) in the setting of positive COVID-19 serum IgG antibodies [ 18 ]. Imaging features of post-infectious peripheral neuropathy are not specific to the infectious agent and include nerve enlargement, loss of fascicular architecture, and signal hyperintensity and hypoechogenicity on MR neurography and ultrasound respectively.…”

Section: Nervesmentioning

confidence: 99%

Musculoskeletal involvement of COVID-19: review of imaging

et al. 2021

View full text Add to dashboard Cite

The global pandemic of coronavirus disease 2019 (COVID-19) has revealed a surprising number of extra-pulmonary manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. While myalgia is a common clinical feature of COVID-19, other musculoskeletal manifestations of COVID-19 were infrequently described early during the pandemic. There have been emerging reports, however, of an array of neuromuscular and rheumatologic complications related to COVID-19 infection and disease course including myositis, neuropathy, arthropathy, and soft tissue abnormalities. Multimodality imaging supports diagnosis and evaluation of musculoskeletal disorders in COVID-19 patients. This article aims to provide a first comprehensive summary of musculoskeletal manifestations of COVID-19 with review of imaging.

show abstract

“…A PubMed search was performed using the following combinations of keywords: neuralgic amyotrophy, SARS-CoV-2, COVID-19, and brachial plexopathy. It revealed only 3 case reports in the literature [5][6][7], till the time of writing ( Table 1). The report of Cacciavillani et al includes a patient who developed pure sensory neuralgic amyotrophy, possibly related to infection with SARS-CoV-2, without any clinical or electrophysiological signs of motor nerve involvement.…”

Section: Discussionmentioning

confidence: 99%

“…To our knowledge, only 3 case reports have documented neuralgic amyotrophy in association with SARS-CoV-2 infection in the literature [5][6][7]. Herein, we present a case of severe, bilateral asymmetric neuralgic amyotrophy in a 32-year-old male, in association with laboratory-confirmed infection with SARS-CoV-2.…”

Section: Introductionmentioning

confidence: 90%